Healthcare & Pharmaceutical Market Intelligence
Ethiopia represents one of Africa's largest long-term pharmaceutical demand markets, driven by its massive population, expanding public healthcare system, and increasing healthcare investment.
≈132M
Population
USD 429M
Pharma Imports
80–85%
Import Dependency
USD 0.9–1.1B
Pharma Market
≈25.8%
Infertility Prevalence
Long-Term Growth Potential
Pharmaceutical Ecosystem
80–85%
Imported Medicines
≈70%
EPSA Market Role
15–25%
Private Sector & Retail
15–20%
Local Manufacturing
USD 429M Imports • USD 2.33M Exports
Women's Health & Fertility Epidemiology
≈25.8%
Pooled infertility prevalence (2025 meta-analysis)
≈22.8%
Primary infertility (pooled estimate)
≈12.7%
Secondary infertility (pooled estimate)
58.8%
Female factor infertility (SPHMMC • Addis Ababa)
62.4%
Male factor infertility among couples at a fertility center
Sources: Ethiopia 2025 Systematic Review & Meta-analysis • St. Paul's Hospital Millennium Medical College (SPHMMC), Addis Ababa • OEC (HS30) 2024 • EPSA • EFDA • WHO • World Bank • IQVIA
Key Contributors
Tubal infertility & PID
Hormonal disorders
Infections & oxidative stress
Delayed diagnosis
Limited access to fertility care
One of Africa's largest long-term pharmaceutical demand markets
30–32M women of reproductive age
80–85% of medicines are imported
Supplements market of USD 220–320M, growing 10–14% a year
Specialized fertility services expanding but still underpenetrated
